The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Gupta B, Kumar N. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev. 2017;26(2):107–118. doi:10.1097/CEJ.0000000000000249
   PubMed Web of Science ®Google Scholar
• Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–387. doi:10.1136/gutjnl-2014-308124
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Dicker D, Pain A, et al.; Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–527. doi:10.1001/jamaoncol.2015.0735
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-6
   PubMed Web of Science ®Google Scholar
• Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89(17):1277–1284. doi:10.1093/jnci/89.17.1277
   PubMed Web of Science ®Google Scholar
• Lee CH, Wu DC, Lee JM, et al. Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer. 2007;43(7):1188–1199. doi:10.1016/j.ejca.2007.01.039
   PubMed Web of Science ®Google Scholar
• De Stefani E, Barrios E, Fierro L. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. III: oesophageal cancer. Eur J Cancer. 1993;29A(5):763–766. doi:10.1016/S0959-8049(05)80363-6
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–2252. doi:10.1056/NEJMra035010
   PubMed Web of Science ®Google Scholar
• Taylor PR, Qiao YL, Abnet CC, et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1414–1416. doi:10.1093/jnci/djg044
   PubMedGoogle Scholar
• Abnet CC, Lai B, Qiao YL, et al. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst. 2005;97(4):301–306. doi:10.1093/jnci/dji042
   PubMedGoogle Scholar
• Businello G, Parente P, Mastracci L, et al. The pathologic and molecular landscape of esophageal squamous cell carcinogenesis. Cancers. 2020;12(8):2160. doi:10.3390/cancers12082160
   PubMed Web of Science ®Google Scholar
• Dell’Angelica EC, Bonifacino JS. Coatopathies: genetic disorders of protein coats. Annu Rev Cell Dev Biol. 2019;35:131–168. doi:10.1146/annurev-cellbio-100818-125234
   PubMed Web of Science ®Google Scholar
• Martinelli D, Dionisi-Vici C. AP1S1 defect causing MEDNIK syndrome: a new adaptinopathy associated with defective copper metabolism. Ann N Y Acad Sci. 2014;1314:55–63. doi:10.1111/nyas.12426
   PubMed Web of Science ®Google Scholar
• Nevitt T, Ohrvik H, Thiele DJ. Charting the travels of copper in eukaryotes from yeast to mammals. Biochim Biophys Acta. 2012;1823(9):1580–1593. doi:10.1016/j.bbamcr.2012.02.011
   PubMed Web of Science ®Google Scholar
• Brady DC, Crowe MS, Turski ML, et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 2014;509(7501):492–496. doi:10.1038/nature13180
   PubMed Web of Science ®Google Scholar
• Turski ML, Brady DC, Kim HJ, et al. A novel role for copper in Ras/mitogen-activated protein kinase signaling. Mol Cell Biol. 2012;32(7):1284–1295. doi:10.1128/MCB.05722-11
   PubMed Web of Science ®Google Scholar
• Papa L, Manfredi G, Germain D. SOD1, an unexpected novel target for cancer therapy. Genes Cancer. 2014;5(1–2):15–21. doi:10.18632/genesandcancer.4
   PubMedGoogle Scholar
• Ishida S, Andreux P, Poitry-Yamate C, Auwerx J, Hanahan D. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A. 2013;110(48):19507–19512. doi:10.1073/pnas.1318431110
   PubMed Web of Science ®Google Scholar
• Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer. 2012;12(8):540–552. doi:10.1038/nrc3319
   PubMed Web of Science ®Google Scholar
• Theophanides T, Anastassopoulou J. Copper and carcinogenesis. Crit Rev Oncol Hematol. 2002;42(1):57–64. doi:10.1016/S1040-8428(02)00007-0
   PubMed Web of Science ®Google Scholar
• Yang F, Pei R, Zhang Z, et al. Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes. Toxicol in Vitro. 2019;54:310–316. doi:10.1016/j.tiv.2018.10.017
   PubMed Web of Science ®Google Scholar
• Kang Z, Qiao N, Liu G, Chen H, Tang Z, Li Y. Copper-induced apoptosis and autophagy through oxidative stress-mediated mitochondrial dysfunction in male germ cells. Toxicol in Vitro. 2019;61:104639. doi:10.1016/j.tiv.2019.104639
   PubMed Web of Science ®Google Scholar
• Liao J, Yang F, Chen H, et al. Effects of copper on oxidative stress and autophagy in hypothalamus of broilers. Ecotoxicol Environ Saf. 2019;185:109710. doi:10.1016/j.ecoenv.2019.109710
   PubMed Web of Science ®Google Scholar
• Brady DC, Crowe MS, Greenberg DN, Counter CM. Copper chelation inhibits BRAF(V600E)-driven melanomagenesis and counters resistance to BRAF(V600E) and MEK1/2 Inhibitors. Cancer Res. 2017;77(22):6240–6252. doi:10.1158/0008-5472.CAN-16-1190
   PubMed Web of Science ®Google Scholar
• Yoshii J, Yoshiji H, Kuriyama S, et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 2001;94(6):768–773. doi:10.1002/ijc.1537
   PubMed Web of Science ®Google Scholar
• Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Suling H. Classification and prognostic value of serum copper/zinc ratio in Hodgkin’s disease. Biol Trace Elem Res. 2001;83(2):133–138. doi:10.1385/BTER:83:2:133
   PubMed Web of Science ®Google Scholar
• Witkowski K, Kozłowski A, Pardela M, Piecuch J, Walichiewicz P. [Level of copper in plasma and tissue of patients with esophageal and large bowel cancer]. Wiad Lek. 1993;46(15–16):586–588. Polish.
   PubMedGoogle Scholar
• Li YQ, Chen J, Yin JY, Liu ZQ, Li XP. Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients. J Cancer. 2018;9(19):3532–3539. doi:10.7150/jca.26286
   PubMed Web of Science ®Google Scholar
• Yang T, Chen M, Chen T, Thakur A. Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer. Oncol Lett. 2015;10(4):2584–2590. doi:10.3892/ol.2015.3531
   PubMed Web of Science ®Google Scholar
• Mallik S, Zhao Z. Towards integrated oncogenic marker recognition through mutual information-based statistically significant feature extraction: an association rule mining based study on cancer expression and methylation profiles. Quant Biol. 2017;5(4):302–327. doi:10.1007/s40484-017-0119-0
   PubMedGoogle Scholar
• Yin J, Wang L, Tang W, et al. RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population. PLoS One. 2014;9(7):e101705. doi:10.1371/journal.pone.0101705
   PubMed Web of Science ®Google Scholar
• Yin J, Wang X, Zheng L, et al. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One. 2013;8(11):e80570. doi:10.1371/journal.pone.0080570
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43(1):55–59. doi:10.1038/ng.732
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–98. doi:10.1038/sj.cr.7290272
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009;19(4):519–523. doi:10.1038/cr.2009.33
   PubMed Web of Science ®Google Scholar
• Zanconato F, Forcato M, Battilana G, et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17(9):1218–1227. doi:10.1038/ncb3216
   PubMed Web of Science ®Google Scholar
• Maugeri-Saccà M, De Maria R. The Hippo pathway in normal development and cancer. Pharmacol Ther. 2018;186:60–72. doi:10.1016/j.pharmthera.2017.12.011
   PubMed Web of Science ®Google Scholar
• Klee KMC, Janecke AR, Civan HA, et al. AP1S1 missense mutations cause a congenital enteropathy via an epithelial barrier defect. Hum Genet. 2020;139(10):1247–1259. doi:10.1007/s00439-020-02168-w
   PubMed Web of Science ®Google Scholar
• Montpetit A, Côté S, Brustein E, et al. Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet. 2008;4(12):e1000296. doi:10.1371/journal.pgen.1000296
   PubMed Web of Science ®Google Scholar
• Incecik F, Bisgin A, Yılmaz M. MEDNIK syndrome with a frame shift causing mutation in AP1S1 gene and literature review of the clinical features. Metab Brain Dis. 2018;33(6):2065–2068. doi:10.1007/s11011-018-0313-4
   PubMed Web of Science ®Google Scholar
• Alonso N, Wani S, Rose L, Van’t Hof RJ, Ralston SH, Albagha OME. Insertion mutation in Tnfrsf11a causes a Paget’s disease-like phenotype in heterozygous mice and osteopetrosis in homozygous mice. J Bone Miner Res. 2021;36(7):1376–1386. doi:10.1002/jbmr.4288
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Alonso S, Banahan K, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci U S A. 2009;106(25):10272–10277. doi:10.1073/pnas.0811273106
   PubMed Web of Science ®Google Scholar
• Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38(1):27–57. doi:10.1016/j.gtc.2009.01.004
   PubMed Web of Science ®Google Scholar
• Seitz HK, Maurer B, Stickel F. Alcohol consumption and cancer of the gastrointestinal tract. Dig Dis. 2005;23(3–4):297–303. doi:10.1159/000090177
   PubMed Web of Science ®Google Scholar
• Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett. 2016;370(1):33–38. doi:10.1016/j.canlet.2015.10.003
   PubMed Web of Science ®Google Scholar
• Alshabi AM, Vastrad B, Shaikh IA, Vastrad C. Identification of crucial candidate genes and pathways in glioblastoma multiform by bioinformatics analysis. Biomolecules. 2019;9(5):201. doi:10.3390/biom9050201
   PubMed Web of Science ®Google Scholar
• Jacob AG, Smith CWJ. Intron retention as a component of regulated gene expression programs. Hum Genet. 2017;136(9):1043–1057. doi:10.1007/s00439-017-1791-x
   PubMed Web of Science ®Google Scholar
• Hunt R, Hettiarachchi G, Katneni U, et al. A single synonymous variant (c.354G>A [p.P118P]) in ADAMTS13 confers enhanced specific activity. Int J Mol Sci. 2019;20(22):5734. doi:10.3390/ijms20225734
   PubMed Web of Science ®Google Scholar
• Lin L, Lin DC. Biological significance of tumor heterogeneity in esophageal squamous cell carcinoma. Cancers. 2019;11(8):1156. doi:10.3390/cancers11081156
   PubMed Web of Science ®Google Scholar